Using PCa cell lines from racially diverse prostate tumors, it was found that glucocorticoids upregulated two stress oncoproteins related to PCa therapeutic resistance, Clusterin (CLU) and lens epithelium-derived growth factor p75 (LEDGF/p75), while glucocorticoid inhibition blocked this effect. Here, CLU is linked to prostate neoplasm.